337 related articles for article (PubMed ID: 30111667)
61. Synthesis, Biological Evaluation and Docking Study of New Pyrimidine Compounds as Anticancer Agents.
Boumi S; Moghimirad J; Ostad SN; Amanlou M; Tavajohi S; Amini M
Drug Res (Stuttg); 2021 May; 71(5):284-290. PubMed ID: 33285580
[TBL] [Abstract][Full Text] [Related]
62. Discovery of novel pyrrolo-pyridine/pyrimidine derivatives bearing pyridazinone moiety as c-Met kinase inhibitors.
Wang LX; Liu X; Xu S; Tang Q; Duan Y; Xiao Z; Zhi J; Jiang L; Zheng P; Zhu W
Eur J Med Chem; 2017 Dec; 141():538-551. PubMed ID: 29107421
[TBL] [Abstract][Full Text] [Related]
63. Synthesis, Anticancer Activity, Effect on Cell Cycle Profile, and Apoptosis-Inducing Ability of Novel Hexahydrocyclooctathieno[2,3-d]pyrimidine Derivatives.
Kassab AE; Gedawy EM; El-Malah AA; Abdelghany TM; Abdel-Bakky MS
Chem Pharm Bull (Tokyo); 2016; 64(5):490-6. PubMed ID: 27150481
[TBL] [Abstract][Full Text] [Related]
64. Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers.
Subba Rao AV; Swapna K; Shaik SP; Lakshma Nayak V; Srinivasa Reddy T; Sunkari S; Shaik TB; Bagul C; Kamal A
Bioorg Med Chem; 2017 Feb; 25(3):977-999. PubMed ID: 28034647
[TBL] [Abstract][Full Text] [Related]
65. Design and synthesis of novel pyrazolo[1,5-a]pyrimidine derivatives bearing nitrogen mustard moiety and evaluation of their antitumor activity in vitro and in vivo.
Zhao M; Ren H; Chang J; Zhang D; Yang Y; He Y; Qi C; Zhang H
Eur J Med Chem; 2016 Aug; 119():183-96. PubMed ID: 27162123
[TBL] [Abstract][Full Text] [Related]
66. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
67. Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents.
Zhou P; Huang L; Zhou J; Jiang B; Zhao Y; Deng X; Zhao Q; Li F
Bioorg Med Chem Lett; 2017 Sep; 27(17):4185-4189. PubMed ID: 28757067
[TBL] [Abstract][Full Text] [Related]
68. Sulfamic acid promoted one-pot synthesis of phenanthrene fused-dihydrodibenzo-quinolinones: Anticancer activity, tubulin polymerization inhibition and apoptosis inducing studies.
Kumar NP; Thatikonda S; Tokala R; Kumari SS; Lakshmi UJ; Godugu C; Shankaraiah N; Kamal A
Bioorg Med Chem; 2018 May; 26(8):1996-2008. PubMed ID: 29525336
[TBL] [Abstract][Full Text] [Related]
69. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
[TBL] [Abstract][Full Text] [Related]
70. Design and synthesis of piperazine acetate podophyllotoxin ester derivatives targeting tubulin depolymerization as new anticancer agents.
Sun WX; Ji YJ; Wan Y; Han HW; Lin HY; Lu GH; Qi JL; Wang XM; Yang YH
Bioorg Med Chem Lett; 2017 Sep; 27(17):4066-4074. PubMed ID: 28757065
[TBL] [Abstract][Full Text] [Related]
71. Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents.
Conesa-Milián L; Falomir E; Murga J; Carda M; Meyen E; Liekens S; Alberto Marco J
Eur J Med Chem; 2018 Mar; 147():183-193. PubMed ID: 29432949
[TBL] [Abstract][Full Text] [Related]
72. Synthesis and biological evaluation of novel pyrazolo[3,4-b]pyridines as cis-restricted combretastatin A-4 analogues.
Jian XE; Yang F; Jiang CS; You WW; Zhao PL
Bioorg Med Chem Lett; 2020 Apr; 30(8):127025. PubMed ID: 32063430
[TBL] [Abstract][Full Text] [Related]
73. Design, synthesis and biological evaluations of chirally pure 1,2,3,4-tertrahydroisoquinoline analogs as anti-cancer agents.
Ramanivas T; Sushma B; Nayak VL; Chandra Shekar K; Srivastava AK
Eur J Med Chem; 2015 Mar; 92():608-18. PubMed ID: 25615796
[TBL] [Abstract][Full Text] [Related]
74. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
75. Synthesis and antitumor activity of 2-aryl-1, 2, 4-triazolo[1, 5-a] pyridine derivatives.
Tao X; Hu Y
Med Chem; 2010 Mar; 6(2):65-9. PubMed ID: 20412047
[TBL] [Abstract][Full Text] [Related]
76. Discovery of Novel 3-Cyanopyridines as Survivin Modulators and Apoptosis Inducers.
Sabour R; Harras MF; Mohamed Al Kamaly O; Altwaijry N
Molecules; 2020 Oct; 25(21):. PubMed ID: 33105831
[TBL] [Abstract][Full Text] [Related]
77. Synthesis and mechanistic aspects of 2-anilinonicotinyl-pyrazolo[1,5-a]pyrimidine conjugates that regulate cell proliferation in MCF-7 cells via estrogen signaling.
Kamal A; Faazil S; Hussaini SM; Ramaiah MJ; Balakrishna M; Patel N; Pushpavalli SN; Pal-Bhadra M
Bioorg Med Chem Lett; 2016 Apr; 26(8):2077-83. PubMed ID: 26948540
[TBL] [Abstract][Full Text] [Related]
78. Design, synthesis, and cytotoxic activity of novel 2H-imidazo[1,2-c]pyrazolo[3,4-e]pyrimidine derivatives.
Zheng YG; Pei X; Xia DX; Wang YB; Jiang P; An L; Huang TH; Xue YS
Bioorg Chem; 2021 Apr; 109():104711. PubMed ID: 33609916
[TBL] [Abstract][Full Text] [Related]
79. Novel selenylated imidazo[1,2-a]pyridines for breast cancer chemotherapy: Inhibition of cell proliferation by Akt-mediated regulation, DNA cleavage and apoptosis.
Almeida GM; Rafique J; Saba S; Siminski T; Mota NSRS; Filho DW; Braga AL; Pedrosa RC; Ourique F
Biochem Biophys Res Commun; 2018 Sep; 503(3):1291-1297. PubMed ID: 30017191
[TBL] [Abstract][Full Text] [Related]
80. Design, synthesis and biological evaluation of novel 6-substituted pyrrolo [3,2-d] pyrimidine analogues as antifolate antitumor agents.
Tian C; Wang M; Han Z; Fang F; Zhang Z; Wang X; Liu J
Eur J Med Chem; 2017 Sep; 138():630-643. PubMed ID: 28711701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
